Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:GENE

Genetic Technologies (GENE) Stock Price, News & Analysis

Genetic Technologies logo

About Genetic Technologies Stock (NASDAQ:GENE)

Advanced Chart

Key Stats

Today's Range
$0.77
$0.77
50-Day Range
$0.77
$0.77
52-Week Range
$0.67
$3.77
Volume
N/A
Average Volume
N/A
Market Capitalization
$3.37 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive GENE Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Genetic Technologies and its competitors with MarketBeat's FREE daily newsletter.

GENE Stock News Headlines

This stock could leave NVDA in the dust
Investing Legend Hints the End May be Near for These 3 Iconic Stocks Futurist Eric Fry say Amazon, Tesla and Nvidia are all on the verge of major disruption. To help protect anyone with money invested in them, he's sharing three exciting stocks to replace them with. He gives away the names and tickers completely free in his brand-new "Sell This, Buy That" broadcast.tc pixel
AI meets CRISPR for precise gene editing
See More Headlines

GENE Stock Analysis - Frequently Asked Questions

Genetic Technologies shares reverse split on Monday, December 4th 2023.The 1-5 reverse split was announced on Monday, December 4th 2023. The number of shares owned by shareholders was adjusted after the market closes on Monday, December 4th 2023. An investor that had 100 shares of stock prior to the reverse split would have 20 shares after the split.

Based on aggregate information from My MarketBeat watchlists, some other companies that Genetic Technologies investors own include Netflix (NFLX), Plug Power (PLUG), Meta Platforms (META), OPKO Health (OPK), Nokia (NOK), Novavax (NVAX) and iBio (IBIO).

Company Calendar

Today
8/22/2025
Fiscal Year End
6/30/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Biological products, except diagnostic
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:GENE
CIK
1166272
Employees
50
Year Founded
1989

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
0.01
Current Ratio
0.88
Quick Ratio
0.83

Sales & Book Value

Annual Sales
$7.66 million
Price / Sales
0.44
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.25 per share
Price / Book
3.06

Miscellaneous

Outstanding Shares
4,407,000
Free Float
4,534,000
Market Cap
$3.37 million
Optionable
Optionable
Beta
1.12

Social Links

 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.

Get This Free Report

This page (NASDAQ:GENE) was last updated on 8/23/2025 by MarketBeat.com Staff
From Our Partners